Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06453629 · ClinicalTrials.gov registry record · NA

RCT to Evaluate Social Skills in Children With Autism Using VR Technology (SoCaVR)

A NA study of Autism Spectrum Disorder and Social Communication, sponsored by Floreo.

Active
Registry status
NA
Development phase
100
Enrollment target
17
Study locations

NCT06453629 is a NA study of Autism Spectrum Disorder and Social Communication that is active but no longer recruiting, run by Floreo. The registered enrollment target is 100 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (26% lower). The trial reports 17 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06453629, a NA study of Autism Spectrum Disorder and Social Communication, is active but no longer recruiting, sponsored by Floreo.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
17
Study locations

Study Summary

The goal of this randomized clinical trial is to compare and learn about Virtual Reality (VR) in children with autism/Autistic children. The main question it aims to answer is: • Does the Floreo VR clinical product show clinical improvement in autism symptoms? Participants will engage the VR product for twice a week for twelve weeks. They will be randomized to either the Floreo Clinical Product or a VR Control group experience. Researchers will compare the two groups to see if there is an effect on learning specific skills and behaviors.

Interventions

  • DEVICE Floreo VR
  • DEVICE VR Control
  • DEVICE VR Control Crossover

Study Locations (17)

California

  • Cortica- Carlsbad - Carlsbad
  • Cortica- Glendale - Glendale
  • Cortica- Irvine - Irvine
  • Cortica- Laguna Niguel - Laguna Niguel
  • Cortica- San Diego - San Diego
  • Cortica- Marin - San Rafael
  • Cortica- Torrance - Torrance
  • Cortica- Westlake Village - Westlake Village

Massachusetts

  • Cortica- Burlington - Burlington
  • Cortica- Dedham - Dedham
  • Cortica- Shrewsbury - Shrewsbury

Connecticut

  • Cortica- Ridgefield - Ridgefield
  • Cortica- Trumbull - Trumbull

Illinois

  • Cortica- Naperville - Naperville
  • Cortica- Westchester - Westchester

Texas

  • Cortica- Plano - Plano
  • Cortica- The Woodlands - The Woodlands

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2024-05-31
Est. Completion 2026-03-15
Phase NA

Sponsor

Floreo

2 total trials

What the Registry Record Tells You About NCT06453629

The ClinicalTrials.gov registry entry for NCT06453629 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (26% lower). The listed sponsor is Floreo, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 3 interventions - of which Floreo VR is the first listed.

NCT06453629 reports 17 study locations spanning 5 distinct geographic areas - top geographies include California, Massachusetts, Connecticut.

Frequently Asked Questions

What is clinical trial NCT06453629 about?

NCT06453629 is a clinical study titled "RCT to Evaluate Social Skills in Children With Autism Using VR Technology (SoCaVR)". The goal of this randomized clinical trial is to compare and learn about Virtual Reality (VR) in children with autism/Autistic children. The main question it aims to answer is: • Does the Floreo VR clinical product show clinical improvement in autism symptoms? Participants will engage the VR prod...

What is the current status of trial NCT06453629?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-05-31. Estimated completion is 2026-03-15.

What conditions does trial NCT06453629 study?

This clinical trial studies the following conditions: Autism Spectrum Disorder, Social Communication.

What interventions are being tested in trial NCT06453629?

The interventions under investigation include: Floreo VR (DEVICE), VR Control (DEVICE), VR Control Crossover (DEVICE).

Who is sponsoring clinical trial NCT06453629?

This trial is sponsored by Floreo, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06453629 being conducted?

This trial has 17 study locations across California, Connecticut, Illinois, Massachusetts, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism Spectrum Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.